DOCSLIB.ORG

Iranian Pharmaceuticals Industry Analysis Report

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Iranian Pharmaceuticals Industry Analysis Report Iranian Pharmaceuticals Industry Analysis Report Summary to the efficiency of the domestic companies This report provides a brief overview on by investigating the structure of productions macro pharmaceutical Industry in Iran. It and compare these productions in the existing identifies and gives a broad introduction to consumer market. In this regard the optimal the investment opportunities in this sector. As production structure and effective control well as assessing the actual and potential over the market sales, as well as high quality advantages and challenges of the industry, productions and productions in the saturated this report includes a briefing on global market has been reviewed to observe the market, followed by the strengths and appropriate investment options in this sector. weaknesses of the industry in regional terms. It has also been tried to get an in-depth insight 1 2018. Key factors affecting the Global pharmaceutical industry pharmaceutical industry in the world on both the supply and demand sides can The pharmaceutical industry is one of be divided into the following categories: the most profitable industries in the world. The stable upward trend along with low a. Population (including population and fluctuations are the distinctive features of this age distribution of the population) sector. Increase in population growth with According to the World Health Organization fundamental and sensitive individual’s need (WHO) world’s population is expected to to health care, has led the industry to increase by one billion people over the next undertake a growing trend. The 10 years and respectively there will be 500 pharmaceutical sector has been less and later million people increase to the population of exposed to economic fluctuations and it has aged over 50 years. been less affected by the economic cycle of boom and recession in comparison to other industries. At present, the volume of pharmaceutical b. GDP per capita industry in the world is almost over one General increase in income and living trillion US dollars, although this amount will standards has always been associated with have been exceeded to 1600 billion dollars by health cost. Income increase, change in the world’s c. Health insurance development and population by age, increase in health status of increase in government health population and changes in life style behavior expenditure of the public, has led us to face a variety of Increase in living standards is always more different illnesses than in the past. For associated with governmental public health example, infectious diseases have been concern, increase in government spending, reduced while chronic diseases and special and the growth in health insurance. disease (cancer, diabetes, neurological, and d. Research and Development: cardiovascular) are increasing, however, High level of cost in research phase is as a their treatment regime is long, complicated key factor affecting pharmaceutical and expensive. industry’s supply side. Patent protection 2 allows a manufacturing company to recoup figure expected to rise to US$400 billion the cost of developing of a particular drug and within three years. The 30% global R&D to enjoy a period of exclusive right to market, funding share in respect to the whole Industry an innovator drug called “brand name”. After reflects its impact on Pharmaceutical expiring a patent on a drug any manufacturing. pharmaceutical company can manufacture The figure blow illustrates the geographic and sell the drug that defines as “generic”. distribution of generic and brand drugs The global annual spending on research and consumption: development is worth US$300 billion, a IMS Outlook for the Global approval of new invented drugs and increase Pharmaceutical Industry: in the number of patients. Consumer spending on diabetes medications Spending levels will be driven by branded in developed and developing countries will drugs primarily in developed markets, along experience an increase of 10%. with the greater use of generics in pharma New hepatitis drug sales growth will be the emerging markets-offset by the impact of next focus by reducing the period of patent expires. treatment, definitive treatment and side the uptick in the number of approvals of the effects new molecular entities (NMEs), leading to a Focus on therapeutic areas related to cancer, new wave of innovation and invention in the diabetes and hepatitis will be important for industry companies’ growth at the global level. Sales of drugs related to the cancer will have the most growth with consideration to 3 The industry sales will experience slower fields like pharmaceutical growth until 2018 after the increasing trend biotechnology in 2014 and 2015, - Pharmaceutical spending is close to Major growth is related to reduction of 20% of total treatment costs expired brand drugs in this period, the - 10 largest companies hold close to production of new medicines and price 50% market share and 10 importing increases. The growth rate is projected to be drugs companies hold more than 73% between 4 to 7 percent. of the importing drug market. Iranian Pharmaceuticals Industry - In terms of value, Antibiotics consumption is nearly a quarter of all Key facts: drug consumption in Iran - Iran is a large pharmaceutical market - Nearly a third of market sales is in the region and has undergone great linked to sales of brand medicines. growth in comparison with - 15 percent increase in the developing countries and the pharma pharmaceutical industry's sales is emerging group, and the market is predicted by the World Health expanding quickly while a major Organization (WHO). share goes to biotechnology drugs, which implies the need to commercialization activities in novel In the following table, market share of Cancer %8 medicines in Iran, according to their therapeutic areas are specified. Endocrinology %5.8 Hematology %5.2 Therapeutic group Shares in drug consumption Respiratory %4 Infection %17 Dermatology %2.6 CNS %10 Gynecology %2.1 Cardiovascular %8.3 4 Population Population growth is an important variable Iran demographic trend for the period 1990- which affects the drug consumption and 2014 is presented in the following diagram. consequently profitability of pharmaceutical industry. 90000000 80000000 70000000 60000000 50000000 40000000 30000000 20000000 10000000 0 up 65 population Population Growth and Aging are “cost if the use and cost of drugs increase with age drivers,” that influences spending on for the average individual within the prescription drugs, Population growth is the population. According to the statistics, in the effect of changes in the size of the population last 4 years, Iran population growth rate has on total drug spending. Other things being been stable at around 1.3%, which shows an equal, an increase in population size will slightly growth compared to previous years. increase total spending. Population aging is Based on population policies, it is predictable the effect of changes in the age distribution of that population growth stays constant or the population on spending. An aging increase slightly in near future. population will result in increased spending . 5 Age groups and medical expenses: 8 7 6 5 4 3 2 1 0 0-1 1-5 5-20 20-40 40-60 up 60 Above figure shows the relative differences in health care costs by age groups. Age composition of the population according to 2010 Census is presented in the following graph: 10000000 9000000 8000000 7000000 6000000 5000000 4000000 3000000 2000000 1000000 0 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 up 80 As shows the above figure, the highest share of the population is accounted for by those aged 25–29. currently by aging of this group, there has been an increase in the median age of the Iran’s population which still have the highest share of the population .Considering the different segment of population, healthcare costs and that the large portion of total population is young the level of health care costs and medication consumption is minimum. Therefor by the aging of the population, spending on health and social care in medium to long term will increase inexorably in Iran. Indicators of health costs in Iran is provided in the following table: 6 Health expenditure (% of Health Health GDP) expenditure, expenditure total public (% of per capita Series Name population, total private public government (current expenditure) US$) 3.70 1.94 1.75 7.45 85 61,306,632 1995 4.09 2.10 1.98 8.46 109 62,426,086 1996 4.51 2.32 2.19 9.72 133 63,616,065 1997 4.59 2.65 1.95 9.16 176 6,780,362 1998 4.60 2.68 1.91 10.61 229 65,850,062 1999 5.09 2.87 2.22 11.88 291 66,812,736 2000 5.12 2.87 2.25 10.09 101 67,696,677 2001 4.74 2.57 2.17 9.81 96 68,522,074 2002 4.72 2.67 2.05 10.12 116 69,321,953 2003 5.33 2.97 2.36 9.58 155 70,122,115 2004 5.07 2.72 2.35 9.26 173 70,923,164 2005 5.11 2.83 2.28 10.53 219 71,720,859 2006 6.35 3.87 2.49 10.07 311 72,530,693 2007 7.20 4.19 3.01 13.31 355 73,370,982 2008 7.28 4.44 2.84 13.43 413 74,253,373 2009 6.26 3.56 2.70 13.87 479 75,184,322 2010 6.64 3.96 2.68 17.53 485 76,156,975 2011 6.69 3.96 2.73 17.53 432 77,152,445 2012 .
Load more

Recommended publications
  • Iran Chamber of Commerce,Industries and Mines Date : 2008/01/26 Page: 1
    Iran Chamber Of Commerce,Industries And Mines Date : 2008/01/26 Page: 1 Activity type: Exports , State : Tehran Membership Id. No.: 11020060 Surname: LAHOUTI Name: MEHDI Head Office Address: .No. 4, Badamchi Alley, Before Galoubandak, W. 15th Khordad Ave, Tehran, Tehran PostCode: PoBox: 1191755161 Email Address: [email protected] Phone: 55623672 Mobile: Fax: Telex: Membership Id. No.: 11020741 Surname: DASHTI DARIAN Name: MORTEZA Head Office Address: .No. 114, After Sepid Morgh, Vavan Rd., Qom Old Rd, Tehran, Tehran PostCode: PoBox: Email Address: Phone: 0229-2545671 Mobile: Fax: 0229-2546246 Telex: Membership Id. No.: 11021019 Surname: JOURABCHI Name: MAHMOUD Head Office Address: No. 64-65, Saray-e-Park, Kababiha Alley, Bazar, Tehran, Tehran PostCode: PoBox: Email Address: Phone: 5639291 Mobile: Fax: 5611821 Telex: Membership Id. No.: 11021259 Surname: MEHRDADI GARGARI Name: EBRAHIM Head Office Address: 2nd Fl., No. 62 & 63, Rohani Now Sarai, Bazar, Tehran, Tehran PostCode: PoBox: 14611/15768 Email Address: [email protected] Phone: 55633085 Mobile: Fax: Telex: Membership Id. No.: 11022224 Surname: ZARAY Name: JAVAD Head Office Address: .2nd Fl., No. 20 , 21, Park Sarai., Kababiha Alley., Abbas Abad Bazar, Tehran, Tehran PostCode: PoBox: Email Address: Phone: 5602486 Mobile: Fax: Telex: Iran Chamber Of Commerce,Industries And Mines Center (Computer Unit) Iran Chamber Of Commerce,Industries And Mines Date : 2008/01/26 Page: 2 Activity type: Exports , State : Tehran Membership Id. No.: 11023291 Surname: SABBER Name: AHMAD Head Office Address: No. 56 , Beside Saray-e-Khorram, Abbasabad Bazaar, Tehran, Tehran PostCode: PoBox: Email Address: Phone: 5631373 Mobile: Fax: Telex: Membership Id. No.: 11023731 Surname: HOSSEINJANI Name: EBRAHIM Head Office Address: .No.
    [Show full text]
  • Credit Rating Companies with Multi-Criteria Decision Making Models and Artificial Neural Network Model
    J. Basic. Appl. Sci. Res., 3(5)536-546, 2013 ISSN 2090-4304 Journal of Basic and Applied © 2013, TextRoad Publication Scientific Research www.textroad.com Credit Rating Companies with Multi-Criteria Decision Making Models and Artificial Neural Network Model Maghsoud Amiri1, Mehdi Biglari Kami*2 1Allameh Tabatabaei University, Tehran, Iran 2Institute of Higher Education Raja, Qazvin, Iran ABSTRACT This research seeks to develop a procedure for credit rating of manufacturing corporations accepted in Tehran stock exchange. So, financial ratios of 181 manufacturing corporations in Iran stock exchange were extracted, These ratios reflect the financial ability to pay principal and interest of loan. Initially, fifty selected corporations ranked by using TOPSIS method based on financial ratios by using of Shannon entropy will be obtained the weight of each criterion. In addition, classification credit with neural network has compared by logistic regression; and finally, each had more credibility, used to rank all corporations. Then all corporations have classified by neural network. Finally, the neural network classification results compared with the expert classification. About 95% of the neural network data has placed in its respective class, and the data results indicated a robust neural network classification based on training. The neural network offered far more accurate answer than the logistic regression in this classification. At the end, the neural network ranked all corporations, and neural network classification results compared with expert opinion, showing that the neural network classification was very close to an expert opinion. KEYWORDS: Financial ratios; TOPSIS; Artificial neural network; Logistic regression. INTRODUCTION Today, the credit industry plays an important role in the economy of corporations.
    [Show full text]
  • June 2017 No 127, Volume 11
    June 2017 - Volume 11, No 127 Presidential elections were held in Iran on 19 May 2017 with a participation rate of 73%. Summary Equity Markets The Tehran Stock Exchange rose 1% in local currency terms in the month of May and with the Iranian rial appreciating against the US$, the overall index gained nearly 2% in US$ terms over the month. The market’s total trading volume was 81% higher than in April, rising from US$ 1.1 billion to US$ 2.0 billion, while the total number of shares traded rose 55% from 20 billion to 31 billion. Economic Review This issue addresses recent developments in Iran’s E-commerce sector, focusing on the latest government and private sector initiatives that have driven this booming market. In addition we have included sections covering the latest macroeconomic data published by relevant organizations and senior macroeconomic strategists in a factsheet report, as well as an economic calendar released by local and international statistics centers. 1 Iran Investment Monthly Table of Contents 3 Market Overview 3 Market Insight 6 Performance & Updates 8 Sector Insight 11 Company Overview 12 Market Snapshot 13 TSE & Junior Market Performance 14 Top Ranked Companies 15 TSE Statistics 15 FX Movements 16 Iran’s Fixed Income Market 20 Economic Review 20 Latest Updates 23 Macroeconomic Data 24 Turquoise Partners 24 About Turquoise Partners 28 News & Views 2 Iran Investment Monthly Market Overview Market Insight June 2017 - Volume 11, No 127 Market Insight Iran’s main stock market extended its positive year-to-date (YTD) performance in Rial terms, edging up 1.15% in local currency terms in the month of May.
    [Show full text]
  • Annual Report Annual Report
    Tehran Stock Exchange Annual Report Exchange 2011 Stock Tehran Tehran Stock Exchange Address: No.228,Hafez Ave. Tehran - Iran Tel: (+98 021) 66704130 - 66700309 - 66700219 Fax: (+98 021) 66702524 Zip Code: 1138964161 Gun-metal relief discovered in Lorestan prov- ince, among the Achaemedian dynasty’s (550-330 BC)Antiquities. Featuring four men, hand in hands, indicating unity and cooperation; standing inside circles of 2011 globe,which is it, according to Iranian ancient myths, put on the back of two cows, ANNUAL symbols of intelligence and prosperity. Tehran Stock Exchange Implementation: CAPITAL&MARKET REPORT ANNUAL REPORT Tehran Stock Exchange 2011 Tehran Stock Exchange Tehran www.tse.ir Annual Report 2011 2 Tehran Stock Exchange Tehran www.tse.ir Mission Statement To develop a fair, efficient and transparent market equipped with diversified instruments and easy access in order to create added value for the stakeholders. Vision To be the region’s leading Exchange and country’s economic growth driver. Goals To increase the capital market’s share in financing the economic productive activities. To apply the effective rules and procedures to protect the market’s integrity and shareholders’ equity. To expand the market through using updated and efficient technology and processes. To promote financial literacy and develop investing and shareholding culture in Iran. To extend and facilitate the market access through information technology. To create value for shareholders and comply with transparency and accountability principles, with cooperation
    [Show full text]
  • 1 アフガニスタン Islamic Republic of Afghanistan Al Qa
    国名、地域名 企業名､組織名 別名 懸念区分 Ｎｏ． Country or Region Company or Organization Also Known As Type of WMD ・The Base ・Al Qaeda ・Islamic Salvation Foundation ・The Group for the Preservation of the アフガニスタン Holy Sites 化学 1 Islamic Republic of Al Qa'ida/Islamic Army ・The Islamic Army for the Liberation of C Afghanistan Holy Places ・The World Islamic Front for Jihad against Jews and Crusaders ・Usama Bin Laden Network ・Usama Bin Laden Organisation ・Safa Nicu Sepahan アフガニスタン ・Safanco Company 核 2 Islamic Republic of Safa Nicu ・Safa Nicu Afghanistan Company N Afghanistan ・Safa Al-Noor Company ・Safa Nicu Ltd Company アフガニスタン Islamic Republic of Afghanistan 核 3 Ummah Tameer E-Nau (UTN) N パキスタン Islamic Republic of Pakistan アラブ首長国連邦 生物、化学、ミ 4 United Arab Energy Global International FZE サイル、核 Emirates B,C,M,N アラブ首長国連邦 ミサイル 5 United Arab International General Resourcing FZE M Emirates アラブ首長国連邦 核 6 United Arab Modern Technologies FZC (MTFZC) N Emirates アラブ首長国連邦 ・PetroIran Petroiran Development Company (PEDCO) ミサイル、核 7 United Arab ・PEDCO Ltd M,N Emirates ・National Iranian Oil Company - PEDCO アラブ首長国連邦 核 8 United Arab Qualitest FZE N Emirates ・Safa Nicu Sepahan アラブ首長国連邦 ・Safanco Company 核 9 United Arab Safa Nicu ・Safa Al-Noor Company N Emirates ・Safa Nicu Ltd Company イスラエル 核 10 Ben-Gurion University (of the Negev) State of Israel N イスラエル 核 11 Nuclear Research Center Negev (NRCN) State of Israel N ・7th of Tir Complex ・7th of Tir Industrial Complex イラン ・7th of Tir Industries 核 12 Islamic Republic of 7th of Tir ・7th of Tir Industries of Isfahan/Esfahan N Iran ・Mojtamae Sanate Haftome Tir ・Sanaye Haftome Tir ・Seventh of Tir 1 / 32 ページ イラン 核 13 Islamic Republic of Abadan Oil Refining Company ・Abadan Oil Refining Co.
    [Show full text]
  • Pdf 322.03 K
    IJVS 2016; 11(1); Serial No:24 IRANIAN JOURNAL OF VETERINARY SURGERY (IJVS) WWW.IVSA.IR Evaluating the Feasibility of Esophagotomy Suture Line Reinforcement Using Platelet Rich Fibrin Membrane and Its Effect on Wound Healing Amidreza Jeyrani Moghaddam1, Davoud Kazemi*2 Abstract Objective- This study aimed to evaluate the feasibility of using platelet rich fibrin membrane as a novel on-lay patching biomaterial in canine esophagotomy and its effects on esophageal wound healing. Design- Experimental study. Animals- Eight adult mixed breed dogs of both sexes equally allocated to control and treatment groups. Procedures- Longitudinal incisions measuring 3 cm were made in the cervical esophagus of all dogs (2 incisions in each dog). All incisions were sutured and on-lay patching was performed in four dogs using platelet rich fibrin. After 28 days, wound healing was assessed by macroscopic, histological and biochemical methods Results- Patching resulted in less adhesion formation (18.24 vs. 61.67 mm, p<0.05) and increase in tissue hydroxyproline content (91.31 vs. 74.31 mg, p>0.05). Histologically, platelet rich fibrin membrane mostly influenced wound healing in the outer layers of the esophagus particularly the muscular layer although a slightly better wound healing was observed overall. Conclusion and Clinical Relevance- Platelet rich fibrin membrane could be used as an alternative patching biomaterial in esophageal surgery although further investigations needs to be carried out particularly in clinical cases. Key words- Platelet rich fibrin membrane, Onlay patching, Esophagus, Dog, Wound healing. Introduction The resultant product is a true biomaterial containing platelets, leukocytes and growth factors trapped inside a Esophagotomy is commonly performed to remove dense network of fibrin clot.
    [Show full text]
  • Market Transaction Trade Resumption 11-May-2016 Trading Halt 11
    11-May-2016 Market Transaction Trade resumption 11-May-2016 Name Opening Price Etebari Iran Co-R (RKSH) ----------- Nirou Trans-R (NIRO) 4000R Parsian Ecommerc(EPRS) -------- Neiriz Cement (SSNR) ------- Buali Inv (BALI) --------- Nirou Trans-R (NIRO) 4000R Khazar Shipping(KHZZ) 7950R Sabzevar Cement(SBZZ) 732R Pegah Fars Co(GFRZ) 3630R Alborz Invest(ETLZ) 1351R Trading halt 11- May -2016 Name Closing Price Reasons Kh. Pegah Dairy (SPKH) 5797 R General Assembly Inf. Services (INFO) 18795 R General Assembly Gharb Cement (SGRB) 2763 R General Assembly 4689 R Extraordinary assembly in case of choosing board Boroujerd T (BROJ) members Banks Employees-R (SKBV) 5 R End of underwriting Bahman Inv.-R(SBAH) 493R End of underwriting Baghmishe(BGHZ) 2702R Adjusted EPS Zagros Petro(PZGZ) 11,199R General Assembly Alborz Bulk Co(BLKZ) 4,715R General Assembly Saadi Tile(KSAD) 1,979R Adjusted EPS Sand Foundry(TAMI) 1,930R Adjusted EPS www.behgozinbroker.com 11-May-2016 Block trading 11-May -2016 Name Number of Shares Price Kharazmy Invest (IKHR) 25,500,000 1355R Bank Melli Inv (BANK) 25,000,000 2400R Mobarakeh Steel (FOLD) 10,152,000 1377R Sina Fin. Ins (VSIN) 7,500,000 1377R Atye Damavand (ATDM) 5,500,000 2184R The best industry groups (in terms of volume) 11- May -2016 Industry Index Change Best Trade(Value) Automotives & autoparts -2.49% Iran Khodro (IKCO) Basic Metals -0.49% Isfahan Steel(ZOBZ) Investment Companies -1.16% Saipa Inv (SSAP) Conglomerates -0.55% Omid Inv. Mng (OIMC) Bank -0.20% Saderat Bank (BSDR) Chemical and petrochemical -0.41% Shazand Petr (PARK) Metalic products -3.19% Azarab Ind (AZAB) www.behgozinbroker.com 11-May-2016 There are some changes in active shareholders ,we summarize the important ones.
    [Show full text]
  • The Network Analysis of Tehran Stock
    The Network Analysis of Tehran Stock Exchange using Minimum Spanning Tree and Hierarchical Clustering Salman Abbasian-Naghneh Associate Prof., Department of Financial Management, Masjed-Soleiman Branch, Islamic Azad University, Masjed-Soleiman, Iran. (Email: [email protected]) Reza Tehrani * *Corresponding author, Prof., Faculty of Management, University of Tehran, Tehran, Iran. (Email: [email protected]) Mohammad Tamimi Associate Prof., Department of Financial Management, Masjed-Soleiman Branch, Islamic Azad University, Masjed-Soleiman, Iran. (Email: [email protected]) Document Type: Original Article 2020, Vol. 4, No. 2. 1-18 Received: 2019/08/09 Accepted: 2020/09/22 Published: 2020/10/13 Abstract Nowadays, financial markets in Iran have attracted the attention of many managers, investors and financial policymakers. Therefore, in order to make the optimal decision and reduce the risks in such a market, it is important to identify and analyze the network behavior of the financial markets at different times to obtain the optimal decision. The current study aims to answer the following research question; how is it possible to use the minimum spanning tree and hierarchical clustering in the network analysis of the Tehran Stock Exchange? The period examined was 2013 to 2018. The population consisted of all the companies accepted in Tehran Stock Exchange. The sampling was selected purposefully and contained the companies which had at least one trading day in the time span from the beginning of 2013 to the end of 2018. The stock of the investigated companies was considered as the vertexes of one graph and the coherent information criterion was considered as the weight of the edge.
    [Show full text]
  • Identification and Ranking Performance Indicators Using ISM and BWM Methods in Companies Listed in Tehran Stock Exchange
    Original Article Identification and Ranking performance Indicators Using ISM and BWM Methods in Companies Listed in Tehran Stock Exchange 1 2 2 Saber Amjadian , Ata Mohammadi *, Behzad Parvizi 1 Ph.D. student in Accounting, Sanandaj Branch, Islamic Azad University of Sanandaj, Iran.2 Assistant professor in Accounting, Accounting group, Sanandaj Branch, Islamic Azad University, Sanandaj, Iran, Abstract The current research sought to present a model for evaluating the financial performance of companies active in Tehran stock exchange. T this end, 50 financial ratios proposed by experts were utilized, among which, 49 ratios were finalized. These ratios were categorized into 6 groups including consolidation, economic, leverage, liquidity, profitability and activity. According to the experts` views, these ratios were weighted and analyzed using multivariate decision making criteria of BWM and Aras technique as well as Lingo software. Finally, the companies were ranked; among the existing 516 companies whose ratios were accessible, the investigations were conducted. The results indicated that Iran mineral salts company, Golgohar mining and industrial company and Khouzestan steel company obtained 1 to 3 rankings, respectively. Keywords: Performance evaluation, Financial ratios, The best worst method, Tehran stock exchange controlling in the production and finally improving the INTRODUCTION products or presenting services. Edward Deming has emphasized on the fact that all business processes should be In fact, if it is not possible to measure what is being spoken a part of evaluation system along with the feedback cycle. of, and if it is not possible to express the intended meaning Jac Fitz Enz believed that evaluating every business activity in terms of numbers, it seems that nothing has been is an essential issue.
    [Show full text]
  • Annual Report 2017/18
    18 / 2017 Annual Report Annual Report 2017/18 Contents Saman Bank in 2017/18 Statement of the Board and the CEO ............................................................................ 5 Key Figures .................................................................................................................... 7 About Saman Bank ........................................................................................................ 8 Saman’s position in the Securities and Exchange Organisation .............................. 12 The Bank’s Legal Environment .................................................................................. 12 An Overview of Saman’s Operational and Financial Performance ........................... 14 Resource and Expense Analysis ................................................................................. 19 Major Achievements of Bank in Different Areas ........................................................ 22 Corporate Governance ................................................................................................ 34 Senior Executive Team ............................................................................................... 37 Division Heads ............................................................................................................. 38 Independent Audit ....................................................................................................... 38 Human Capital ............................................................................................................
    [Show full text]
  • April & May 2017 No 126, Volume 11
    April & May 2017 - Volume 11, No 126 Tochal Mountain, Tehran. April 2017. Summary Equity Markets The Tehran Stock Exchange has made steady gains over the past two months, rising 2.0% in March and 2.9% in April in US$ terms. During the final month of the last Iranian calendar year (from 19 Feb to 21 Mar 2017), the market’s total trade value increased 91% compared to the previous month, from 1.1 billion US$ to 2.1 billion US$, while the number of shares traded rose 78% from 20 billion shares to 36 billion. Economic Review This issue reviews the economic performance, consumption value in GDP and trade balance in the Iranian cal- endar year 1395 (March 2016 to March 2017). In addition, we have included sections covering the latest macro- economic data published by relevant organizations and senior macroeconomic strategists in a factsheet report, as well as an economic calendar released by local and international statistics centres. 1 Iran Investment Monthly Table of Contents 3 Market Overview 3 Market Insight 6 Performance & Updates 8 Sector Insight 11 Company Overview 12 Market Snapshot 14 TSE & Junior Market Performance 16 Top Ranked Companies 18 TSE Statistics 18 FX Movements 20 Iran’s Fixed Income Market 24 Economic Review 24 Latest Updates 26 Macroeconomic Data 29 Turquoise Partners 29 About Turquoise Partners 31 News & Views 2 Iran Investment Monthly Market Overview Market Insight April & May 2017 - Volume 11, No 126 Rouhani: 4 More Years Results of the Iranian presidential election were announced on the morn- ing of Saturday 20th May and showed that the incumbent, Hassan Rou- hani, comfortably defeated his conservative rival with a winning margin of approximately 57% to 39%.
    [Show full text]
  • Q3 2016 Iran
    Q3 2016 www.bmiresearch.com IRAN PHARMACEUTICALS & HEALTHCARE REPORT INCLUDES 10-YEAR FORECASTS TO 2025 Published by:BMI Research Iran Pharmaceuticals & Healthcare Report Q3 2016 INCLUDES 10-YEAR FORECASTS TO 2025 Part of BMI’s Industry Report & Forecasts Series Published by: BMI Research Copy deadline: May 2016 ISSN: 1748-1953 BMI Research © 2016 Business Monitor International Ltd Senator House All rights reserved. 85 Queen Victoria Street London All information contained in this publication is EC4V 4AB copyrighted in the name of Business Monitor United Kingdom International Ltd, and as such no part of this Tel: +44 (0) 20 7248 0468 publication may be reproduced, repackaged, Fax: +44 (0) 20 7248 0467 redistributed, resold in whole or in any part, or used Email: [email protected] in any form or by any means graphic, electronic or Web: http://www.bmiresearch.com mechanical, including photocopying, recording, taping, or by information storage or retrieval, or by any other means, without the express written consent of the publisher. DISCLAIMER All information contained in this publication has been researched and compiled from sources believed to be accurate and reliable at the time of publishing. However, in view of the natural scope for human and/or mechanical error, either at source or during production, Business Monitor International Ltd accepts no liability whatsoever for any loss or damage resulting from errors, inaccuracies or omissions affecting any part of the publication. All information is provided without warranty, and Business Monitor International Ltd makes no representation of warranty of any kind as to the accuracy or completeness of any information hereto contained.
    [Show full text]